BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2002
View Archived Issues
Versicor and Pharmacia focus on improving activity and spectrum of oxazolidinones
Read More
EMEA recommends approval for desloratadine syrup and rapidly disintegrating tablets
Read More
Lexicon validates new drug target in depression
Read More
Sepracor and 3M join forces to manufacture Xopenex HFA metered-dose inhaler
Read More
Vertex moves new drug candidate VX-799 into development for sepsis
Read More
Successful completion of clinical trial of inhaled human growth hormone
Read More
Actimmune enters phase II trial for treatment of liver fibrosis
Read More
Pilot study evaluates Natrecor in chronic heart failure outpatients
Read More
Avaden hormone replacement therapy receives French approval
Read More
Prescient NeuroPharma licenses anhydrovinblastine to Access Oncology
Read More
Major European launch announced for Kaletra
Read More
Endothelial cell-specific inhibition of protein synthesis demonstrated for tumstatin
Read More
Antisense oligonucleotide targeting Ki-ras as an approach to colorectal cancer
Read More
Specific, small-molecule inhibitor of P-selectin with antiinflammatory properties
Read More
Cell adhesion inhibitor IS-741 effective in rat model of IBD
Read More
Potent and selective OX2 receptor antagonists identified by Banyu
Read More
Gastric and cholecystokinin receptor ligands claimed in patents by James Black researchers
Read More
New Kissei compounds have potential for lowering lipids and protecting the liver
Read More
HGS and CAT form TRAIL-R1 antibody partnership
Read More
5-HT7 receptor antagonists synthesized at BMS
Read More
Solvay presents piperazine and piperidine compounds and potential uses
Read More
CD40-targeted MAb moves to clinical development at Genentech
Read More
Alexion's 5G1.1 completes phase I pilot study
Read More
DGI BioTechnologies and Novo Nordisk enter collaboration for cancer agents
Read More
CSL obtains marketing and distribution license to Angiomax in Australia
Read More
Two phase II trials of Neotrofin initiated in chemotherapy-induced neuropathy
Read More
MC-1 receives FDA approval for entry into phase II
Read More